Relay Therapeutics Inc (RLAY): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Relay Therapeutics Inc
Mitarbeiter 202
Handelsplatz NASDAQ
Ticker Symbol RLAY
IPO Datum 2020-07-16
Adresse 60 Hampshire Street, Cambridge, MA, United States, 02139
Webseite https://www.relaytx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS | CEO, President & Director |
| 2 | Dr. Mark Murcko Ph.D. | Founder & Independent Director |
| 3 | Mr. Thomas Catinazzo | Chief Financial Officer |
| 4 | Mr. Peter Rahmer | Chief Corporate Development Officer |
| 5 | Dr. Donald A. Bergstrom M.D., Ph.D. | President of Research & Development |
| 6 | Ms. Dorothee Kern Ph.D. | Founder |
| 7 | Dr. David Elliot Shaw Ph.D. | Founder |
| 8 | Dr. Matthew P. Jacobson Ph.D. | Founder |
| 9 | Mr. Jim Watters Ph.D. | Chief Scientific Officer |
| 10 | Ms. Soo-Yeun Lim J.D. | Senior VP & General Counsel |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 12,73% | 0,53 Mrd. USD |
| 2 | COMMODORE CAPITAL LP | 7,76% | 0,32 Mrd. USD |
| 3 | Casdin Capital, LLC | 7,32% | 0,30 Mrd. USD |
| 4 | Perceptive Advisors LLC | 6,44% | 0,27 Mrd. USD |
| 5 | BlackRock Inc | 5,92% | 0,25 Mrd. USD |
| 6 | Bellevue Group AG | 3,56% | 0,15 Mrd. USD |
| 7 | Vanguard Capital Management, LLC | 3,37% | 0,14 Mrd. USD |
| 8 | Nextech Invest, Ltd. | 3,09% | 0,13 Mrd. USD |
| 9 | State Street Corp | 2,84% | 0,12 Mrd. USD |
| 10 | TCG Crossover Management, LLC | 1,95% | 0,08 Mrd. USD |
| 11 | FMR Inc | 1,69% | 0,07 Mrd. USD |
| 12 | Geode Capital Management, LLC | 1,60% | 0,07 Mrd. USD |
| 13 | Westfield Capital Management Company, L.P. | 1,53% | 0,06 Mrd. USD |
| 14 | Kynam Capital Management, LP | 1,51% | 0,06 Mrd. USD |
| 15 | Dimensional Fund Advisors, Inc. | 1,43% | 0,06 Mrd. USD |
| 16 | Balyasny Asset Management LLC | 1,39% | 0,06 Mrd. USD |
| 17 | Spruce Street Capital LP | 1,36% | 0,06 Mrd. USD |
| 18 | The Goldman Sachs Group Inc | 1,16% | 0,05 Mrd. USD |
| 19 | MPM Oncology Impact Management LP | 1,10% | 0,05 Mrd. USD |
| 20 | Pictet Asset Manangement SA | 0,95% | 0,04 Mrd. USD |